🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

John L. Hays

Ohio State University Hospital

ORCID: 0000-0003-3140-8677

Also affiliated with The Ohio State University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment.

31 citations

Christina M. Annunziata, John L. Hays, Liang Cao, Peter L. Choyke, Minshu Yu +8 more

0 citations

Jacob S. Yount, Jason J. David, Mindy Hoang, Colin W. Stets, Tanios Bekaii‐Saab +6 more

0 citations

Sarah Crafton, Jason J. David, Colin W. Stets, Nicholas Grosenbacher, James Lin Chen +2 more

19 citations

Alison M. Newton, Sara Conroy, Anita Adib, Neema C. Adley, Scott A. Strassels +7 more

2 citations

Roberta M. Ray, Alison M. Newton, Sandi L. Navarro, Jeannette M. Schenk, Holli A. Loomans‐Kropp +5 more

4 citations

Leah R. Jager, Alison M. Newton, Xilin Li, Holli A. Loomans‐Kropp, John L. Hays +3 more

2 citations

Sarah G. Wilkins, Varun Bansal, David Su, Jorge L. Gomez‐Mayorga, Kiran K. Turaga +11 more

1 citations

Wafa Khadraoui, John L. Hays, Larry J. Copeland, Roberto Vargas, David M. O’Malley +2 more

0 citations

Rakhsha Khatri, Patrick L. Quinn, Joanne Kim, Mary Dillhoff, Aslam Ejaz +7 more